marrubenol | 560-58-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: marrubenol
• 英文别名: (1R,3R,4R,4aS,8S,8aS)-4-[2-(furan-3-yl)ethyl]-8-(hydroxymethyl)-3,4a,8-trimethyl-2,3,5,6,7,8a-hexahydro-1H-naphthalene-1,4-diol
• CAS: 560-58-7
• 化学式: C₂₀H₃₂O₄
• 分子量: 336.472
• InChiKey: NZMHIKFTAXRIDL-FQFOHHTNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  73.8
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  夏至草素 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 1.0h， 生成 marrubenol
  参考文献：
  名称：

  The Vasorelaxant Activity of Marrubenol and Marrubiin from Marrubium vulgare

  摘要：

  马鲁卜草（Marrubium vulgare）地上部分的粗提取物在体外显示出对KCl诱导的大鼠主动脉收缩具有强效抑制作用。生物指导分级、光谱分析和化学衍生化揭示了呋喃类拉班二萜化合物marrubenol和marrubiin是最活跃的成分。

  DOI：

  10.1055/s-2003-37042

文献信息

• Cocker et al., Journal of the Chemical Society, 1953, p. 2540,2546
  作者：Cocker et al.

  DOI：——

  日期：——
• MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD
  申请人：Puranox Medical B.V.

  公开号：EP1915166A2

  公开（公告）日：2008-04-30
• COMPOSITION FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTIONS CAUSED BY RETROVIRUSES
  申请人：Pandalis, Georgios

  公开号：EP2846814A1

  公开（公告）日：2015-03-18
• Marrubiin and Composition For Reducing Snoring, Package and Method
  申请人：Brand Hans Marcel

  公开号：US20080305192A1

  公开（公告）日：2008-12-11

  The invention comprises a composition for the reduction of snoring, a packaging therefor and a method for the manufacture hereof. The composition can be applied in the pharynx in different variants, in particular as spray, as gel or as foam formulation. Application of the composition at least temporarily reduces the snoring of a treated person. The invention further comprises the use of marrubiin for the manufacture of a medication for the treatment of snoring.
• Marrubiin and composition for reducing snoring, package and method
  申请人：Brand Hans Marcel

  公开号：US20110305780A1

  公开（公告）日：2011-12-15

  The invention comprises a composition for the reduction of snoring, a packaging therefor and a method for the manufacture thereof. The composition can be applied in the pharynx in different variants, in particular as spray, as gel or as foam formulation. Application of the composition at least temporarily reduces the snoring of a treated person. The invention further comprises the use of marrubiin for the manufacture of a medication for the treatment of snoring.